A Blood-Based Test for Epidermal Growth Factor Receptor Mutations in Lung Cancer

This publication has 16 references indexed in Scilit:

• Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer
  Clinical Cancer Research, 2006
• A Correlation between EGFR Gene Mutation Status and Bronchioloalveolar Carcinoma Features in Japanese Patients with Adenocarcinoma
  Japanese Journal of Clinical Oncology, 2006
• Mutations of the epidermal growth factor receptor in non-small cell lung cancer – Search and destroy
  European Journal Of Cancer, 2006
• The development of imatinib as a therapeutic agent for chronic myeloid leukemia
  Blood, 2005
• Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
  JNCI Journal of the National Cancer Institute, 2005
• Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
  PLoS Medicine, 2005
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility
  Annals of the New York Academy of Sciences, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004